Cancer vaccines based on mRNA technology are showing encouraging results against some of the world’s hardest-to-treat cancers, including melanoma, pancreatic cancer and glioblastoma. The same technology used to develop COVID-19 vaccines at record speed is now being tested to train the immune system to recognise and destroy cancer cells. In addition, researchers say the field has become one of the…
Tag: Roche
-
Trade Tariffs and Their Impact on Pharmaceuticals
The pharmaceutical industry is bracing for a significant financial blow. Analysts forecast costs of between $13 billion and $19 billion following a new transatlantic trade deal. This deal will subject branded medicines to a hefty 15% tariff. Officials confirmed the landmark trade agreement between the European Union and the United States on Sunday. It marks the end of the historic…
-
Immunotherapy for Cancer and Early-Stage Success
Ground-breaking advancements in immunotherapy are poised to transform cancer care. New data reveal the effectiveness of these immune-boosting drugs in treating a wider range of cancers at their earlier stages. Previously established as life-extending treatments for advanced diseases, drugs such as Bristol Myers Squibb’s Opdivo, AstraZeneca’s Imfinzi, and Roche’s Tecentriq are now demonstrating significant promise. They are preventing recurrence and…
-
Roche sues over alleged misuse of trade secrets
Roche has filed a lawsuit in the California federal court against Stanford University and medical technology startup Foresight Diagnostics, alleging that Foresight misappropriated its genetic-sequencing trade secrets to develop competing cancer-detection products. In the complaint, Roche claims that Stanford University professors Maximilian Diehn and Ash Alizadeh, whose technology Roche acquired in 2015, secretly established Foresight while serving as consultants for…